Tandem Diabetes Care Inc (OQ:TNDM)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 12400 High Bluff Drive
Tel: N/A
Website: https://www.tandemdiabetes.com
IR: See website
Key People
Leigh A. Vosseller
Chief Financial Officer, Executive Vice President, Treasurer
David B. Berger
Chief Operating Officer, Executive Vice President
Susan M. Morrison
Executive Vice President, Chief Administrative Officer
Elizabeth A. Gasser
Executive Vice President, Chief Strategy Officer
Brian B. Hansen
Chief Commercial Officer, Executive Vice President
Shannon M. Hansen
Senior Vice President, Chief Compliance Officer, General Counsel, Chief Privacy Officer and Secretary
James A. Leal
Senior Vice President - Operations
Rick Carpenter
Chief Technical Officer
Business Overview
Tandem Diabetes Care, Inc. is a medical device company. The Company is focused on the design, development, and commercialization of technology solutions for people living with diabetes. It manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. Its manufacturing, sales, and support activities principally focus on its flagship pump platform, the t:slim X2, and its complementary product offerings. Its t:slim X2 is based on the Company's technology platform and is the smallest durable insulin pump available in the United States. The Company has commercially offered two different automated insulin dosing (AID) algorithms on t:slim X2, including Control-IQ technology, which is an advanced hybrid-closed loop feature, designed to help increase a user's time in their targeted glycemic range. It was cleared by the Food and Drug Administration (FDA) to deliver automatic correction boluses in addition to adjusting insulin to help prevent high and low blood sugar.
Financial Overview
For the three months ended 31 March 2023, Tandem Diabetes Care Inc revenues decreased 4% to $169.4M. Net loss increased from $14.7M to $123.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Other Selling, general and administ. increase of 23% to $75.7M (expense), Research and development - Balancing val increase of 28% to $36.7M (expense).
Employees: 2,600 as of Dec 31, 2022
Reporting Currency: U.S. Dollars
Enterprise value: $1,365M as of Mar 31, 2023
Annual revenue (TTM): $794.69M as of Mar 31, 2023
EBITDA (TTM): -$191.23M as of Mar 31, 2023
Net annual income (TTM): -$203.75M as of Mar 31, 2023
Free cash flow (TTM): -$30.80M as of Mar 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 64,621,839 as of Apr 28, 2023
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.